Tuberculosis transmission and use of methamphetamines in Snohomish County, WA, 1991-2006

American Journal of Public Health

Volumn 100, Issue 12, 2010, Pages 2481-2486

  Pevzner, Eric S ^a   Robison, Susan ^b   Donovan, Jenny ^b   Allis, Donna ^b   Spitters, Chris ^b,c   Friedman, Rachel ^a   Ijaz, Kashef ^a   Oeltmann, John E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Snohomish Health District   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

ADDICTION; ADOLESCENT; ADULT; ARTICLE; CHILD; CONTACT EXAMINATION; COOPERATION; DISEASE TRANSMISSION; DRUG ABUSE; EPIDEMIC; FEMALE; HUMAN; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MALE; MASS SCREENING; MENTAL HEALTH SERVICE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PRESCHOOL CHILD; REFUSAL TO PARTICIPATE; RISK FACTOR; TUBERCULOUS PLEURISY; UNITED STATES;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; CHILD; CHILD, PRESCHOOL; CONTACT TRACING; COOPERATIVE BEHAVIOR; DISEASE OUTBREAKS; FEMALE; HUMANS; LATENT TUBERCULOSIS; MALE; MASS SCREENING; MENTAL HEALTH SERVICES; METHAMPHETAMINE; MIDDLE AGED; REFUSAL TO PARTICIPATE; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; TUBERCULOSIS, PLEURAL; TUBERCULOSIS, PULMONARY; WASHINGTON; YOUNG ADULT;

EID: 78649891260     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2009.162388     Document Type: Article

References (35)

1. Reichman LB, Felton CP, Edsall JR. Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med. 1979;139(3):337-339.
2. Centers for Disease Control and Prevention. Crack cocaine use among persons with tuberculosis-Contra Costa County, California, 1987-1990. MMWR Morb Mortal Wkly Rep. 1991;40(29):485-489.
3. Kline SE, Hedemark LL, Davies SF. Outbreak of tuberculosis among regular patrons of a neighborhood bar. N Engl J Med. 1995;333(4):222-227.
4. Leonhardt KK, Gentile F, Gilbert BP, Aiken M. A cluster of tuberculosis among crack house contacts in San Mateo County, California. Am J Public Health. 1994; 84(11):1834-1836.
5. Malakmadze N, Gonzalez IM, Oemig T, et al. Unsuspected recent transmission of tuberculosis among high-risk groups: implications of universal tuberculosis genotyping in its detection. Clin Infect Dis. 2005;40(3):366-373.
6. McElroy PD, Rothenberg RB, Varghese R, et al. A network-informed approach to investigating a tuberculosis outbreak: implications for enhancing contact investigations. Int J Tuberc Lung Dis. 2003;7(12, suppl 3):S486-S493.
7. Oeltmann JE, Oren E, Haddad MB, et al. Tuberculosis outbreak in marijuana users, Seattle, Washington, 2004. EmergInfect Dis. 2006;12(7):1156-1159.
8. Deiss RG, Rodwell TC, Garfein RS. Tuberculosis and illicit drug use: review and update. Clin Infect Dis. 2009;48(1):72-82.
9. Chin DP, Crane CM, Diul MY, et al. Spread of Mycobacterium tuberculosis in a community implementing recommended elements of tuberculosis control. JAMA. 2000;283(22):2968-2974.
10. Curtis R, Friedman SR, Neaigus A, Jose B, Goldstein M, Des Jarlais DC. Implications of directly observed therapy in tuberculosis control measures among IDUs. Public Health Rep. 1994;109(3):319-327.
11. Brassard P, Bruneau J, Schwartzman K, Senecal M, Menzies D. Yield of tuberculin screening among injection drug users. Int J Tuberc Lung Dis. 2004;8(8):988-993.
12. Howard AA, Klein RS, Schoenbaum EE, Gourevitch MN. Crack cocaine use and other risk factors for tuberculin positivity in drug users. Clin Infect Dis. 2002;35(10):1183-1190.
13. LoBue PA, Moser KS. Use of isoniazid for latent tuberculosis infection in a public health clinic. Am J Respir Crit Care Med. 2003;168(4):443-447.
14. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993;328(8):527-532.
15. Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest. 1997;111(5):1168-1173.
16. Blackwell B. Drug therapy: patient compliance. N Engl J Med 1973;289(5):249-252.
17. Oeltmann JE, Kammerer JS, Pevzner ES, Moonan PK. Tuberculosis and substance abuse in the United States, 1997-2006. Arch Intern Med. 2009;169(2):189-197.
18. Snyder DC, Paz EA, Mohle-Boetani JC, Fallstad R, Black RL, Chin DP. Tuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness. Am J Respir Crit CareMed 1999;160(1):178-185.
19. Snohomish Health District. Communicable Disease Report, 2003-2007. Everett, WA: Snohomish Health District; 2009. Available at: http://www.snohd. org/snoComDisease/tempdocs/CD-Report-2007.pdf. Accessed August 1, 2009.
20. Barnes PF, Cave MD. Molecular epidemiology of tuberculosis. N Engl J Med. 2003;349(12):1149-1156.
21. Centers for Disease Control and Prevention. Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep. 2005;54(RR-15):1-47.
22. Cantrell FL, Breckenridge HM, Jost P. Transrectal methamphetamine use: a novel route of exposure. Ann Intern Med. 2006;145(1):78-79.
23. Spitters CM, Columbel C, Yang Z, Cave MD. Control of an ongoing tuberculosis outbreak involving a disad- vantaged social network. Poster presented at: Third Annual Meeting of the International Union Against Tuberculosis and Lung Disease-North American Region; February 26-29, 1998; Vancouver, BC, Canada.
24. Nordahl TE, Salo R, Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J Neuropsychiatry Clin Neurosci. 2003;15(3):317-325.
25. Sommers I, Baskin D, Baskin-Sommers A. Metham-phetamine use among young adults: health and social consequences. Addict Behav. 2006;31(8):1469-1476.
26. Mansergh G, Purcell DW, Stall R, et al. CDC consultation on methamphetamine use and sexual risk behavior for HIV/STD infection: summary and suggestions. Public Health Rep. 2006;121(2):127-132.
27. Iseman MD. A Clinician's Guide to Tuberculosis. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
28. Mahajan SD, Hu Z, Reynolds JL, Aalinkeel R, Schwartz SA, Nair MP. Methamphetamine modulates gene expression patterns in monocyte derived mature dendritic cells: implications for HIV-1 pathogenesis. Mol Diagn Ther. 2006;10(4):257-269.
29. Fitzpatrick LK, Hardacker JA, Heirendt W, et al. A preventable outbreak of tuberculosis investigated through an intricate social network. Clin Infect Dis. 2001;33(11):1801-1806.
30. Storia DG, Yimer S, Bjune GA. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health. 2008;8:15.
31. Rajbhandary SS, Marks SM, Bock NN. Costs of patients hospitalized for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2004;8(8):1012-1016.
32. Reichler MR, Reves R, Bur S, et al. Treatment of latent tuberculosis infection in contacts of new tuberculosis cases in the United States. South Med J. 2002; 95(4):414-420.
33. Jereb J, Etkind SC, Joglar OT, Moore M, Taylor Z. Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999. Int J Tuberc Lung Dis. 2003;7(12, suppl 3):S384-S390.
34. Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, Nguyen CH. Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med. 2000;162(6):2033-2038.
35. Sprinson JE, Flood J, Fan CS, et al. Evaluation of tuberculosis contact investigations in California. Int J Tuberc Lung Dis.2003;7(12, suppl 3):S363-S368.